Universe Pharmaceuticals (UPC) Inventory Average (2021 - 2025)

Universe Pharmaceuticals (UPC) has 5 years of Inventory Average data on file, last reported at $2.1 billion in Q3 2025.

• For the quarter ending Q3 2025, Inventory Average rose 143.28% year-over-year to $2.1 billion; the trailing twelve-month figure through Sep 2025 stood at $2.1 billion (up 143.28% YoY), and the FY2025 full-year result was $2.1 billion, up 142.86% from the prior year.
• Inventory Average grew to $2.1 billion in Q3 2025, from $868.7 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $953.1 billion in Q3 2021 to a low of $1.2 million in Q3 2022.
• A 5-year average of $119.5 billion and a median of $1.8 million in 2023 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average tumbled 100.0% in 2022 and surged 48827.92% in 2024, its largest moves.
• Tracing UPC's Inventory Average over 5 years: stood at $953.1 billion in 2021, then plunged by 100.0% to $1.2 million in 2022, then surged by 53.71% to $1.8 million in 2023, then surged by 48827.92% to $868.7 million in 2024, then surged by 143.28% to $2.1 billion in 2025.
• Business Quant data shows UPC's Inventory Average at $2.1 billion in Q3 2025, $868.7 million in Q3 2024, and $1.9 million in Q1 2024.